C12N 2750/14311
Parvovirus
Official title: Parvovirus, e.g. minute virus of mice
C12N2750/14311 (Parvovirus) appears on 230 US grants and 247 published applications in this corpus.
Search patents in C12N- Granted patents
- 230
- Published applications
- 247
- Assignees
- 170
- Inventors
- 547
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 3 | 0 |
| 1998 | 16 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 11 | 1 |
| 2002 | 5 | 2 |
| 2003 | 5 | 8 |
| 2004 | 3 | 8 |
| 2005 | 2 | 4 |
| 2006 | 1 | 3 |
| 2007 | 4 | 2 |
| 2008 | 0 | 8 |
| 2009 | 3 | 4 |
| 2010 | 5 | 8 |
| 2011 | 2 | 8 |
| 2012 | 3 | 10 |
| 2013 | 6 | 14 |
| 2014 | 3 | 12 |
| 2015 | 8 | 14 |
| 2016 | 9 | 15 |
| 2017 | 19 | 12 |
| 2018 | 12 | 16 |
| 2019 | 13 | 14 |
| 2020 | 11 | 9 |
| 2021 | 7 | 13 |
| 2022 | 11 | 16 |
| 2023 | 5 | 19 |
| 2024 | 9 | 13 |
| 2025 | 10 | 7 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2750/14322New viral proteins or individual genes, new structural or functional aspects ofIndexing code114
- C12N 2750/14334Use of virus or viral component as vaccineIndexing code68
- C12N 2750/14341Use of virus, viral particle or viral elements as a vectorIndexing code34
- C12N 2750/14351Methods of production or purification of viral materialIndexing code29
- C12N 2750/14332Use of virus as therapeutic agent, other than vaccineIndexing code24
- C12N 2750/14361Methods of inactivation or attenuationIndexing code16
- C12N 2750/14323Virus like particles [vlp]Indexing code13
- C12N 2750/14321Viruses as suchIndexing code12
Recent patents
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs16 Jun 2026US 12,655,427 B2Research Institute At Nationwide Children's Hospital
- Virus inactivation method, method for manufacturing protein drug, and system for purifying solution27 Jan 2026US 12,533,413 B2Able Corporation
- Arthrospira platensis oral vaccine delivery platform21 Oct 2025US 12,447,202 B2Lumen Bioscience, Inc.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Optimized parvovirus H-1 production2 Sep 2025US 12,404,498 B2Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Recombinant adeno-associated virus delivery of exon 2-targeted u7snrna polynucleotide constructs3 Sep 2026US 2026/0258419 A1Research Institute At Nationwide Children's Hospital
- Triple mrna vaccine for preventing feline rhinotracheitis, feline caliciviral disease, and feline panleukopenia, and preparation method thereof6 Aug 2026US 2026/0224690 A1Zhejiang University
- An aav9 capsid variant for targeted gene transfer6 Aug 2026US 2026/0224742 A1Universitaetsklinikum Hamburg-Eppendorf
- Cis and trans requirements for terminal resolution of human bocavirus 130 Apr 2026US 2026/0117253 A1University of Iowa Resarch Foundation
- Rna and dna base editing via engineered adar recruitment2 Apr 2026US 2026/0092292 A1The Regents of the University of California
Most cited
By later US patents
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001
- Genetically engineered vaccine strain89US 5,364,773 AVirogenetics Corporation · 1994